Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: An important role for interleukin-17 during the effector phase

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 879-886

  Flach, Carl Fredrik ^a   Östberg, Anna Karin ^a   Nilsson, Anne Therese ^a   Malefyt, Rene De Waal ^b   Raghavan, Sukanya ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; BETA ACTIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHOLERA TOXIN; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23P19; RECOMBINANT HELICOBATER PYLORI LYSATE VACCINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EFFECTOR CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC CORRELATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VIVO STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TREATMENT RESPONSE;

ANIMALS; BACTERIAL VACCINES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; STOMACH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79251469365     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00756-10     Document Type: Article

References (42)

1. Acosta-Rodriguez, E. V., et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-646.
2. Aebischer, T., et al. 2008. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection. Int. J. Med. Microbiol. 298:161-168.
3. Akhiani, A. A., et al. 2002. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169:6977-6984.
4. Akhiani, A. A., K. Schon, and N. Lycke. 2004. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J. Immunol. 173:3348-3356.
5. Buonocore, S., et al. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371-1375.
6. DeLyria, E. S., R. W. Redline, and T. G. Blanchard. 2009. Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136:247-256.
7. Ermak, T. H., et al. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:2277-2288.
8. Futagami, S., et al. 2006. γδ T cells increase with gastric mucosal interleukin (IL)-7, IL-1β, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis. J. Gastroenterol. Hepatol. 21:32-40.
9. Garhart, C. A., F. P. Heinzel, S. J. Czinn, and J. G. Nedrud. 2003. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin- 12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect. Immun. 71:910-921.
10. Garhart, C. A., R. W. Redline, J. G. Nedrud, and S. J. Czinn. 2002. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70:3529-3538.
11. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
12. Karttunen, R., T. Karttunen, H. P. Ekre, and T. T. MacDonald. 1995. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341-345.
13. Kasuga-Aoki, H., et al. 1999. Tumour necrosis factor and interferon-γ are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 96:122-127.
14. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
15. Kobayashi, M., et al. 2004. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 101:17807-17812.
16. Komiyama, Y., et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566-573.
17. Kusters, J. G., A. H. van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449-490.
18. Lindholm, C., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet, and A. M. Svennerholm. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 66:5964-5971.
19. Luzza, F., et al. 2000. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165:5332-5337.
20. Mattsson, A., H. Lonroth, M. Quiding-Jarbrink, and A. M. Svennerholm. 1998. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Invest. 102:51-56.
21. Moorchung, N., et al. 2006. The role of mast cells and eosinophils in chronic gastritis. Clin. Exp. Med. 6:107-114.
22. Nakae, S., Y. Iwakura, H. Suto, and S. J. Galli. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81:1258-1268.
23. 13C-urea breath test follow-up after eradication. Helicobacter 13:56-61.
24. O'Connor, R. A., et al. 2008. Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181:3750-3754.
25. Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110:55-62.
26. Pappo, J., et al. 1999. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67:337-341.
27. Plessner, H. L., et al. 2007. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J. Infect. Dis. 195:1643-1650.
28. Raghavan, S., M. Hjulstrom, J. Holmgren, and A. M. Svennerholm. 2002. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect. Immun. 70:6383-6388.
29. Raghavan, S., et al. 2010. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect. Immun. 78:4251-4260.
30. Raghavan, S., A. M. Svennerholm, and J. Holmgren. 2002. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect. Immun. 70:4621-4627.
31. Sawai, N., et al. 1999. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 67:279-285.
32. + T cell-mediated IFN-γ response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J. Immunol. 182:7085-7101.
33. Shi, T., W. Z. Liu, F. Gao, G. Y. Shi, and S. D. Xiao. 2005. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-γ correlate with the protection. Helicobacter 10:71-79.
34. Shi, Y., et al. 2010. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol. 184:5121-5129.
35. Shiomi, S., et al. 2008. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter 13:518-524.
36. Suerbaum, S., and P. Michetti. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
37. Suryani, S., and I. Sutton. 2007. An interferon-γ-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J. Neuroimmunol. 183:96-103. (Pubitemid 46204914)
38. Sutton, C. E., et al. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331-341.
39. Sutton, P., et al. 2007. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol. Med. Microbiol. 50:213-219.
40. Svennerholm, A. M., and A. Lundgren. 2007. Progress in vaccine development against Helicobacter pylori. FEMS Immunol. Med. Microbiol. 50:146-156.
41. Velin, D., et al. 2009. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136:2237-2246 e2231.
42. Yamamoto, T., et al. 2004. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol. Immunol. 48:647-654.